Further experiences on experimental cerebral "no-reflow phenomenon"

Area of Science:

• Neurology
• Pharmacology
• Vascular Biology

Background:

• Cerebral ischemia can lead to significant neurological damage.
• Antiedema agents are used to manage complications of ischemia.
• Optimizing drug delivery is crucial for effective treatment.

Purpose of the Study:

• To evaluate the efficacy of combined antiedema pharmacological agents in experimental transient bilateral cerebral ischemia.
• To determine the optimal administration route for improving post-ischemic vascular reperfusion.

Main Methods:

• An experimental model of transient bilateral cerebral ischemia was utilized.
• Various combination groups of antiedema agents, including dexamethasone and furosemide, were tested.
• Different drug and dye injection modalities via the common carotid artery were assessed.

Main Results:

• Dexamethasone and furosemide demonstrated effectiveness as a combination therapy.
• No significant difference in vascular reperfusion was observed when agents were administered alone or simultaneously.
• Injection of antiedema agents through the common carotid artery improved cerebral hemisphere filling.

Conclusions:

• The combination of dexamethasone and furosemide is a potentially useful therapeutic strategy for cerebral ischemia.
• Homogeneous post-ischemic vascular reperfusion is best achieved by bilateral administration of drugs into the common carotid arteries.